Serial pediatric symptom checklist screening in XXXX with prenatal drug exposure.

@entity1 @entity286 @entity2072 @entity1109
OBJECTIVE: To examine screening results obtained by serial annual behavioral assessment of @entity1 with prenatal drug exposure. METHOD: The Maternal Lifestyle Study enrolled @entity1 with prenatal @entity2072 exposure (PCE) at birth for longitudinal assessments of developmental, behavioral, and health outcomes. At 8, 9, 10, 11, and 12 years of age, caregivers rated @entity1 on the @entity1109 ( @entity1109 ). Serial @entity1109 results were compared with an established broad-based behavioral measure at 9, 11, and 13 years. @entity1109 results were analyzed for 1081 @entity1 who had at least 2 annual screens during the 5-year time span. Most subjects (87%) had 4 or more annual screens rated by the same caregiver (80%). @entity1109 scores (and Positive screens) over time were compared at different time points for those with and without PCE. Covariates, including demographic factors and exposures to certain other substances, were controlled. RESULTS: @entity1 with PCE had significantly higher scores overall, with more Positive screens for behavior problems than @entity1 without PCE. @entity1 with PCE had more externalizing behavior problems. @entity1 exposed to @entity286 prenatally and postnatally also showed higher @entity1109 scores. Over time, @entity1109 scores differed slightly from the 8-year scores, without clear directional trend. Earlier @entity1109 results predicted later behavioral outcomes. CONCLUSION: Findings of increased total @entity1109 scores and Positive @entity1109 screens for behavioral concerns in this group of @entity1 with prenatal substance exposure support the growing body of evidence that additional attention to identification of mental health problems may be warranted in this high-risk group.
